The company had net profit of Rs 23.60 crore for the corresponding quarter of 2011-12 fiscal, Ajanta Pharma said in a filing to BSE.
Net sales of the company rose to Rs 249.21 crore during the January-March quarter of 2012-13 fiscal, from Rs 168.61 crore for the same period year ago.
More From This Section
In another filing to the BSE, the company said its board of directors have recommended dividend at the rate of Rs 6.25 per equity share of the face value of Rs 5 each.
Net profit of the company for the year ended March 31, 2013 stood at Rs 101.12 crore as against Rs 66.49 crore for the year ago period.
Net sales of the company for the year ended March 31, 2013 also rose to Rs 828.50 crore from Rs 591.98 crore for the corresponding period previous fiscal year.
Ajanta Pharma scrip closed at Rs 777.05 on the BSE, down 1.81% from its previous close.